- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT04253548
iPeer2Peer Gyermek mellkasátültetés
Az iPeer2Peer támogatási mentorprogram megvalósítása és hatékonyságának értékelése a gyermeki mellkasátültetésen belül
With the on-going presence of a chronic illness, daily immunosuppressive medications, and the need for continuous medical supervision, pediatric transplant recipients face considerable psychosocial stresses. Treatment nonadherence is a major issue in pediatric transplantation and can lead to increased rates of hospitalization, rejection episodes, graft loss and death. An online peer support mentorship program (iPeer2Peer) is proposed as one intervention that could enhance patient care management, increase treatment adherence, reduce social isolation and improve health outcomes for this highly vulnerable population. The proposed trial will determine 1) implementation outcomes of the iPeer2Peer intervention in terms of: (a) feasibility and adoption, (b) acceptability and appropriateness and (c) level of engagement with the program, and 2) effectiveness of the iPeer2Peer intervention on improving health outcomes including disease self-management skills, treatment adherence, quality of life, perceived social support, stress and coping.
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G 1X8
- Hospital for Sick Children
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- heart and/or lung transplant recipient,
- at least 4 months post-transplant,
- between the ages of 12 and 25 years,
- able to speak and read English,
- willingness to commit to 5-10 texts and/or calls of 20-30 minutes each over a period of 15 weeks.
Exclusion Criteria:
- have a significant cognitive impairments as assessed by a qualified healthcare provider,
- have a diagnosis of an active psychological disorder (e.g., Major Depressive Disorder, Generalized Anxiety Disorder) likely to influence assessment of health-related quality of life and/or interfere with their ability to manage their transplant regimen (a diagnosis of an active psychological disorder will be determined for mentees through medical chart review and self-reported by mentors), and
- are participating in other peer support or self-management interventions
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Egyéb
- Kiosztás: N/A
- Beavatkozó modell: Egyetlen csoportos hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Kísérleti: iPeer2Peer Program
Participates in the iPeer2Peer Program |
iPeer2Peer is an online peer support mentorship program that has been established in multiple chronic disease populations as a self-management intervention, including chronic pain and juvenile idiopathic arthritis. The iPeer2Peer program provides modeling and reinforcement by pre-screened and trained young adult peer mentors to adolescent mentees. |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Acceptability: Semi-structured Interview (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Semi-structured Interview |
15 weeks after baseline/immediately after the intervention
|
|
Acceptability: Semi-structured Interview (Mentors)
Időkeret: Study completion, an average of 1 year
|
Semi-structured Interview |
Study completion, an average of 1 year
|
|
Adoption (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Semi-structured Interview |
15 weeks after baseline/immediately after the intervention
|
|
Adoption (Mentors)
Időkeret: Study completion, an average of 1 year
|
Semi-structured Interview |
Study completion, an average of 1 year
|
|
Adoption
Időkeret: Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
Accrual and dropout rates |
Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
|
Adoption
Időkeret: Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
Compliance with iPeer2Peer program |
Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
|
Feasibility: Semi-structured Interview (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Semi-structured Interview |
15 weeks after baseline/immediately after the intervention
|
|
Feasibility: Semi-structured Interview (Mentors)
Időkeret: Study completion, an average of 1 year
|
Semi-structured Interview |
Study completion, an average of 1 year
|
|
Feasibility: Accrual and dropout rates
Időkeret: Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
Accrual and dropout rates |
Mentees - 12 weeks post-program completion; Mentors - study completion, an average of 1 year
|
|
Feasibility: Compliance with iPeer2Peer program (Mentees)
Időkeret: 12 weeks post-program completion
|
Compliance with iPeer2Peer program (an 80% rate of completion of five calls and online outcome measures) |
12 weeks post-program completion
|
|
Feasibility: Compliance with iPeer2Peer program (Mentors)
Időkeret: Study completion, an average of 1 year
|
Compliance with iPeer2Peer program (an 80% rate of completion of five calls and online outcome measures) |
Study completion, an average of 1 year
|
|
Appropriateness (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Semi-structured Interview |
15 weeks after baseline/immediately after the intervention
|
|
Appropriateness (Mentors)
Időkeret: Study completion, an average of 1 year
|
Semi-structured Interview |
Study completion, an average of 1 year
|
|
Level of Engagement (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Semi-structured Interview |
15 weeks after baseline/immediately after the intervention
|
|
Level of Engagement (Mentors)
Időkeret: Study completion, an average of 1 year
|
Semi-structured Interview |
Study completion, an average of 1 year
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Disease self-management skills (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Self-management skills assessment guide (questionnaire); 21-item questionnaire. Each question is scored on a scale from 1 to 5. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Treatment adherence (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Adolescent Medication Barriers Scale; 17-item questionnaire with 3 different sections: Disease Frustration/Adolescent Issues, Ingestion Issues, and Regimen Adaptation/Cognitive. Each question is scored on a scale from 1 to 5. An overall higher score means a worse outcome. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Treatment adherence (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Immunosuppressant Blood Levels |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Treatment adherence (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Clinic Attendance |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Quality of Life (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Pediatric Quality of Life Inventory™ 3.0 Transplant Module; 46-item questionnaire with 8 different sections: About My Medicines I, About My Medicines II, My Transplant and Others, Pain and Hurt, Worry, Treatment Anxiety, How I Look, and Communication. Each question is scored on a scale from 0 to 4. An overall higher score means a better outcome. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Perceived Social Support (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
National Institute of Health Emotional Support Survey; 7-item questionnaire. Each question is scored on a scale from 1 to 5. An overall higher score means a better outcome. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Emotional Distress (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Revised Child Anxiety and Depression Scale - short version; 25-item questionnaire. Each question is scored on a scale with 4 possible responses. An overall higher score means a worse outcome. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Resiliency (Mentees)
Időkeret: Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
Brief Resilience Scale; 6-item questionnaire. Each question is scored on a scale with 5 possible responses. An overall higher score means a better outcome. |
Baseline, 15 weeks after baseline/immediately after the intervention, 12 weeks post-program completion
|
|
Quality of Mentor Behaviour (Mentees)
Időkeret: 15 weeks after baseline/immediately after the intervention
|
Mentor Behaviour Scale; 15-item questionnaire with 4 different sections: Structure, Engagement, Autonomy Support, and Competency Support. Each question is scored on a scale from 1 to 5. |
15 weeks after baseline/immediately after the intervention
|
|
Change in Physical and Emotional Symptoms (Mentors)
Időkeret: Baseline, pre-intervention; study completion, an average of 1 year
|
PROMIS - 29 Adult Profile v2.1; Maximum 29-item questionnaire as responses to some questions may lead participants to answer fewer questions. There are 8 different sections: Physical Function, Anxiety, Depression, Fatigue, Sleep Disturbance, Ability to Participate in Social Roles and Activities, Pain Interference, and Pain Intensity. Each question is scored on a scale from 1 to 5. |
Baseline, pre-intervention; study completion, an average of 1 year
|
|
Change in Perceived Social Role Satisfaction (Mentors)
Időkeret: Baseline, pre-intervention; study completion, an average of 1 year
|
PROMIS Satisfaction with Social Roles and Activities; Maximum 44-item questionnaire as responses to some questions may lead participants to answer fewer questions. Each question is scored on a scale from 1 to 5. An overall higher score means a better outcome. |
Baseline, pre-intervention; study completion, an average of 1 year
|
|
Change in Self-efficacy (Mentors): Chronic Disease Self-Efficacy Scale
Időkeret: Baseline, pre-intervention; study completion, an average of 1 year
|
Chronic Disease Self-Efficacy Scale; 33-item questionnaire with 10 different sections: Exercise Regularly Scale, Get Information About Disease Item, Obtain Help from Community/Family/Friends Scale, Communicate With Physician Scale, Manage Disease in General Scale, Do Chores Scale, Social/Recreational Activities Scale, Manage Symptoms Scale, Manage Shortness of Breath Item, and Control/Manage Depression Scale. Each question is scored on a scale from 1 to 10. An overall higher score means a better outcome. |
Baseline, pre-intervention; study completion, an average of 1 year
|
Együttműködők és nyomozók
Szponzor
Nyomozók
- Kutatásvezető: Samantha J Anthony, PhD, The Hospital for Sick Children
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Egyéb vizsgálati azonosító számok
- 1000065141
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .